Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
03/2007
03/29/2007WO2007010085A2 New pharmaceutical compounds
03/29/2007US20070073093 Light emitting device and compounds for use therein
03/29/2007US20070072871 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
03/29/2007US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/28/2007EP1767535A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
03/28/2007EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds
03/28/2007EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/28/2007CN1938288A 2-aminothiazole compounds useful as aspartyl protease inhibitors
03/28/2007CN1938279A Modulators of atp-binding cassette transporters
03/28/2007CN1935796A Method for preparing nitazoxanide
03/28/2007CN1935795A 2-tert.-butoxyacylamino-3-[4'-2''-methylthiazol-4''-methoxy)-phenyl]-propionic acid and its industralized preparing method and use
03/28/2007CN1307166C Oxazole/thiazol-derivatives activators of the HPPAR-alpha receptor
03/28/2007CN1307165C 4-methyl-5-formylthiazole preparation method
03/28/2007CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
03/27/2007US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis
03/27/2007US7196200 5-oxo-5,8-dihydro[2,3-d]pyrimidinopyridine-6-carboxylic acids or 7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acids; fish or mammals; bacterial protein biosynthesis inhibitors
03/27/2007US7196118 Amidino compounds useful as nitric oxide synthase inhibitors
03/27/2007US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/27/2007US7196107 Thia-and oxazoles and their use as ppars activators
03/27/2007US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7195885 Hepatitis C virus assays
03/27/2007CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
03/22/2007WO2007032028A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
03/22/2007WO2007031513A1 Pesticide thiazolyloxy substituted phenylamidine derivatives
03/22/2007WO2007005785B1 Thiazoles derivatives as ampk activator
03/22/2007WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors
03/22/2007US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis
03/22/2007US20070066586 Aniline derivatives
03/22/2007US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/22/2007US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same
03/22/2007US20070066575 Methods and compositions for mitigating pain
03/22/2007CA2622518A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors
03/22/2007CA2619059A1 Pesticide thiazolyloxy substituted phenylamidine derivatives
03/22/2007CA2617394A1 2-aniline-4-aryl substituted thiazole derivatives
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide
03/21/2007EP1763502A1 Novel hexafluoroisopropanol derivatives
03/21/2007EP1474406B1 Disubstituted thiazolyl carboxanilides and their use as microbicides
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use
03/21/2007CN1934077A 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
03/21/2007CN1933833A Aqueous composition comprising thiazole derivative
03/21/2007CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands
03/20/2007US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/20/2007US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents
03/20/2007CA2220094C Process for producing guanidine derivatives, intermediates therefor and their production
03/15/2007WO2007030618A2 Bicyclic derivatives as modulators of voltage gated ion channels
03/15/2007WO2007029793A1 Aryl heterocyclic derivative and bactericide for agricultural and horticultural use
03/15/2007WO2007029037A2 Class iia histone deacetylase (hdac) substrate
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists
03/15/2007US20070060618 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
03/15/2007US20070060587 Indane derivates as muscarinic receptor agonists
03/15/2007US20070060584 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
03/15/2007US20070060480 Heteroaroyl-substituted phenylalanineamides
03/15/2007CA2622076A1 Bicyclic derivatives as modulators of voltage gated ion channels
03/15/2007CA2621448A1 Class iia histone deacetylase (hdac) substrate
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
03/15/2007CA2621406A1 Pparactive compounds
03/14/2007EP1761511A1 Improved process for the preparation of biologically active tetrahydrobenzthiazole derivative
03/14/2007EP1761486A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1930155A Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
03/14/2007CN1930121A Substituted heteroaryl- and phenylsulfamoyl compounds
03/14/2007CN1927848A Substituted acid compounds, preparation method and medicament use thereof
03/14/2007CN1927843A Compound of 2-substituted alkylacrylate and application thereof
03/14/2007CN1304394C Diastereomeric selective preparation method of lamivudine
03/14/2007CN1304383C Benzothiazole derivatives
03/14/2007CN1304365C Acylated arylcycloalkylamines and their use as pharmaceuticals
03/13/2007US7189857 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives
03/13/2007US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology
03/13/2007US7189751 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis
03/13/2007US7189750 Bis-[4-methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-amine for example; use to treat nitric oxide (NO)-mediated diseases such as cardiovascular diseases, inflammation, tumor suppression and psychiatric and neurological diseases; natural metabolite formed when NO is released, side effect reduction
03/13/2007US7189749 Substituted phenoxyacetic acids
03/13/2007US7189728 Inhibitors of dipeptidyl peptidase IV
03/13/2007US7189722 Aryl spirohydantoin CGRP receptor antagonists
03/13/2007US7189720 Selective NPY (Y5) antagonists
03/08/2007WO2007027134A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS
03/08/2007WO2007027133A1 7-(2-AMINO-1-HYDROXY-ETHYL)-4-HYDROXYBENZOTHIAZOL-2(3H)-ONE-DERIVATIVES AS β2 ADRENOCEPTOR AGONISTS
03/08/2007WO2007026962A1 Phenylene derivative
03/08/2007WO2007026761A1 Thiazole derivative
03/08/2007WO2007026753A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue
03/08/2007WO2005112933A3 Substituted organosulfur compounds and methods of using thereof
03/08/2007US20070055063 Preparation of thiazoles
03/08/2007US20070054909 VLA-4 inhibitor compounds
03/08/2007US20070054904 Phenol derivatives and their use as rotamase inhibitors
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes
03/08/2007US20070054220 Polymeric material containing a latent acid, i.e. a compound which is not an acid but which can be converted to an acid by the influence of laser irradiation
03/08/2007CA2621227A1 Thiazole derivative
03/08/2007CA2620466A1 7-(2-amino-1-hydroxy-ethyl)-4-hydroxybenzothiazol-2(3h)-one-derivatives as .beta.2 adrenoceptor agonists
03/07/2007EP1759698A1 Novel method of treatment
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758874A1 Substituted thiazoleacetic acids as crth2 ligands
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics